Inari Medical Announces First Patient Treated with the ClotTriever™ Thrombectomy System; FDA 510(k) Clearance Received for Peripheral Thrombectomy

IRVINE, CALIFORNIA – April 10, 2017 – Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of venous thrombus, announced the treatment of the first patient with its ClotTriever Thrombectomy System. The ClotTriever Thrombectomy System received 510(k) marketing clearance from the U.S. Food and Drug Administration on February 16 for the non-surgical removal of thrombus (blood clots) from the peripheral vasculature.

+ Read More